Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Ho Hong

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Journal of Drugs in Dermatology : JDD|August 4, 2012
A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of responseHarvey Lui, Wayne Gulliver, Jerry Tan, et al.
Dermatology and Therapy|July 30, 2024
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic DermatitisApril W Armstrong, H Chih-Ho Hong, Brian M Calimlim, et al.
Journal of Cosmetic Dermatology|March 31, 2021
89% Vichy mineralizing water with hyaluronic acid is a well-tolerated adjunct treatment that helps restore skin barrier function in dry skin-related inflammatory dermatoses and post-procedure skin care: A Canadian studyChih-Ho Hong, Jordana Schachter, Allison B Sutton, et al.
Dermatology and Therapy|February 9, 2024
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)Melinda Gooderham, Ronald Vender, Jeffrey Crowley, et al.
Journal of Cutaneous Medicine and Surgery|October 31, 2017
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in AdultsCharles W Lynde, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery|June 6, 2020
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus PaperJensen Yeung, Melinda J Gooderham, Parbeer Grewal, et al.
Dermatology and Therapy|August 8, 2024
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK InhibitorsMark G Kirchhof, Vimal H Prajapati, Melinda Gooderham, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysisJashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
American Journal of Clinical Dermatology|May 27, 2026
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label StudyJoel C Joyce, H Chih-Ho Hong, Dareen D Siri, et al.
Dermatology and Therapy|July 28, 2025
Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16Amy S Paller, Andrew Blauvelt, Weily Soong, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Journal of Drugs in Dermatology : JDD|August 4, 2012
A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of responseHarvey Lui, Wayne Gulliver, Jerry Tan, et al.
Dermatology and Therapy|July 30, 2024
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic DermatitisApril W Armstrong, H Chih-Ho Hong, Brian M Calimlim, et al.
Journal of Cosmetic Dermatology|March 31, 2021
89% Vichy mineralizing water with hyaluronic acid is a well-tolerated adjunct treatment that helps restore skin barrier function in dry skin-related inflammatory dermatoses and post-procedure skin care: A Canadian studyChih-Ho Hong, Jordana Schachter, Allison B Sutton, et al.
Dermatology and Therapy|February 9, 2024
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)Melinda Gooderham, Ronald Vender, Jeffrey Crowley, et al.
Journal of Cutaneous Medicine and Surgery|October 31, 2017
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in AdultsCharles W Lynde, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery|June 6, 2020
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus PaperJensen Yeung, Melinda J Gooderham, Parbeer Grewal, et al.
Dermatology and Therapy|August 8, 2024
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK InhibitorsMark G Kirchhof, Vimal H Prajapati, Melinda Gooderham, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysisJashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
American Journal of Clinical Dermatology|May 27, 2026
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label StudyJoel C Joyce, H Chih-Ho Hong, Dareen D Siri, et al.
Dermatology and Therapy|July 28, 2025
Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16Amy S Paller, Andrew Blauvelt, Weily Soong, et al.
Pageof 10